Minimally Invasive Surgical Instruments Market Size, Share & Trends by Product (Handheld, Inflation Devices, Surgical Scopes), Type of Surgery (Cardiothoracic, Gastrointestional, Bariatric, Orthopedic, Urological), Technology (Non-robotic, Robotic) - Global Forecast to 2029
Report Code: MD 3177 Jun, 2024, by marketsandmarkets.com
Minimally Invasive Surgical Instruments Market Size, Share & Trends
The size of global minimally invasive surgical instruments market in terms of revenue was estimated to be worth $31.7 Billion in 2024 and is poised to reach $49.9 Billion by 2029, growing at a CAGR of 9.5% from 2024 to 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
The rising adoption of minimally invasive surgical procedures is a response to the growing volume of surgical interventions. These techniques are associated with fewer complications and shorter recovery times compared to open surgeries. Consequently, the escalating number of surgeries worldwide is driving the heightened demand for minimally invasive surgical instruments.
Minimally Invasive Surgical Instruments Market Trends
To know about the assumptions considered for the study, Request for Free Sample Report
Minimally Invasive Surgical Instruments Market Dynamics
Driver: Advantages of MIS over open surgical techniques
In recent years, minimally invasive surgeries (MIS) have experienced significant technological advancements, revolutionizing the landscape of surgical procedures in operating rooms. Surgeons increasingly favor advanced MIS techniques such as laparo-endo single-incision surgery (LESS) due to their numerous advantages over traditional open surgical methods. These benefits encompass reduced scarring and tissue damage, expedited recovery times, shorter hospital stays, decreased blood loss and trauma, lower infection risks, and overall cost savings in healthcare. Furthermore, select health insurance providers in certain countries are expanding coverage for minimally invasive surgeries, further fueling patient preference for these procedures.
Restraint: Changing regulatory landscape in the medical device industry
The US FDA now requires more extensive clinical data regarding the safety and efficacy of products. Consequently, companies must invest more in clinical trials, resulting in approval delays and increased capital requirements for thorough post-marketing surveillance studies. Moreover, the risk of product recalls rises, especially for companies lacking funds to conduct additional studies to meet the FDA's data requirements. These approval delays significantly impede the growth of the market.
Opportunity: Increasing adoption of advanced robotics in ASCs
Ambulatory surgery centers (ASCs) are independent facilities specializing in surgical, diagnostic, and preventive procedures that do not necessitate hospital admission. The cost-effectiveness of ASCs yields significant savings for governments, third-party payers, and patients. A joint study by Healthcare BlueBook, a provider of healthcare services data, and HealthSmart, a provider of health plans for self-funded employers, determined that ASCs annually reduce the cost of outpatient surgery by USD 38 billion. This reduction stems from ASCs offering a more cost-effective site of care compared to hospital outpatient departments. Consequently, ASCs, particularly in the US, are increasingly adopting advanced robotics to manage complex cases.
Challenge: High degree of market consolidation
A significant level of consolidation exists among market players, with only major companies capable of affording substantial capital investments and the high costs associated with research and development, as well as manufacturing. This scenario acts as a barrier to entry for new participants attempting to enter the market. Newcomers need to vie against established competitors and differentiate themselves by creating innovative products.
The instruments market is moderately consolidated. The top players— Medtronic PLC (US), Johnson & Johnson (US), Intuitive Surgical Inc. (US), Boston Scientific Corporation (US), Stryker Corporation (US), Abbott Laboratories, Inc. (US), B. Braun SE (Germany), Conmed Corporation (US), Smith + Nephew (UK), Zimmer Biomet Holdings, Inc. (US), Becton, Dickinson and Company (US), The Cooper Companies Inc. (US), Surgical Innovations Group PLC(UK), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation(Japan) in the market accounted for a combined majority market share in 2023. The companies in the sector are fiercely competitive.
Genotyping assay Ecosystem/Market Map
In 2023, handheld instruments segment of the minimally invasive surgical instruments industry accounted for the highest CAGR
The minimally invasive surgical instruments market is mainly divided into into handheld instruments, inflation devices, surgical scopes, cutting instruments, guiding devices, electrosurgical & electrocautery instruments, robotic instruments and other instruments. In 2023, the handheld instruments held the highest share. The limited maneuverability of conventional manual laparoscopic instruments in minimally invasive surgery presents challenges during surgical procedures. As a result, there has been a push for the advancement of articulating laparoscopic surgical instruments that offer improved dexterity at a lower cost. These technological innovations in handheld instruments are contributing significantly to the growth of the market.
In 2023, The robotic surgery segment of the minimally invasive surgical instruments industry is accounted for highest CAGR
By technology, the minimally invasive surgical instruments market is primarily segmented into non-robotic surgery and robotic surgery. In 2023, robotic surgery accounted for the highest CAGR of this market. The benefits of robotic surgery, such as reduced trauma, faster recovery times, and improved outcomes, have led to greater adoption across various surgical specialties. Furthermore, the growing investment in healthcare infrastructure and the rising prevalence of chronic diseases requiring surgical interventions have fueled the demand for robotic MIS procedures. Lastly, favorable reimbursement policies and increased awareness among healthcare professionals and patients about the advantages of robotic surgery have further accelerated its adoption, resulting in the highest CAGR within the MIS market segment.
In 2023, Cardiothoracic segment of the minimally invasive surgical instruments industry is accounted for the highest share
By Type of Surgery, the minimally invasive surgical instruments market is primarily segmented into cardiothoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, cosmetic & bariatric surgery, urological surgery, and other surgeries. The cardiothoracic surgery segment accounted for the largest share of the market in 2023. Minimally invasive cardiothoracic procedures present numerous benefits compared to traditional methods, including decreased surgical trauma, lower blood loss, reduced infection risks, shorter hospital stays (typically 3–5 days), and quicker recovery times (around 2–4 weeks). The increasing occurrence of cardiac disorders serves as a significant driver for the expansion of the cardiothoracic surgery segment. Moreover, with the growing patient population, there's a heightened adoption of advanced technologies for cardiovascular surgeries, which is anticipated to bolster the market growth in this segment.
In 2023, Hospitals and specialty clinics segment of the minimally invasive surgical instruments industry is accounted for the highest share
By end user, the minimally invasive surgical instruments market is primarily segmented into hospitals and specialty clinics and ambulatory surgery centers. The hospitals and specialty clinics segment accounted for a larger share of the market in 2023. Hospitals and specialty clinics stand out as the largest end-user segment within the minimally invasive surgical (MIS) instruments market, primarily due to their execution of intricate diagnostic and therapeutic procedures. These facilities boast superior testing capabilities, streamlined billing processes, state-of-the-art MIS instrumentation, and cost-effective testing services. Consequently, the prevalence of minimally invasive surgical instruments is notably higher in hospitals and specialty clinics, attributed to their robust purchasing capacity, proficient healthcare workforce, and access to advanced surgical facilities.
North America is the largest regional market for minimally invasive surgical instruments industry
The global minimally invasive surgical instruments market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America held the most market share for minimally invasive surgical instruments worldwide in 2023. The expansion of the North American market may be ascribed to the relationship between rising population and rising awareness of MIS.
To know about the assumptions considered for the study, download the pdf brochure
The major players in this market are Medtronic PLC (US), Johnson & Johnson (US), Intuitive Surgical Inc. (US), Boston Scientific Corporation (US), Stryker Corporation (US). The market leadership of these players stems from their comprehensive product portfolios and expanding global footprint. These dominant market players possess several advantages, including strong marketing and distribution networks, substantial research and development budgets, and well-established brand recognition.
Scope of the Minimally Invasive Surgical Instruments Industry
|
Report Metric |
Details |
|
Market Revenue in 2024 |
$31.7 billion |
|
Projected Revenue by 2029 |
$49.9 billion |
|
Revenue Rate |
Poised to Grow at a CAGR of 9.5% |
|
Market Driver |
Advantages of MIS over open surgical techniques |
|
Market Opportunity |
Increasing adoption of advanced robotics in ASCs |
This report categorizes the minimally invasive surgical instruments market to forecast revenue and analyze trends in each of the following submarkets:
By Product
-
Handheld Instruments
- Graspers
- Retractors/Elevators
- Suturing Instruments
- Dilators
- Other Handheld Instruments
-
Inflation Devices
- Balloons
- Balloon Inflation Devices
-
Surgical Scopes
- Laparoscopes
- Urology Endoscopes
- Arthroscopes
- Neuroendoscopes
- Other Surgical Scopes
-
Cutting Instruments
- Trocars
- Other Cutting Instruments
-
Guiding Devices
- Guiding Catheters
- Guidewires
-
Electrosurgical & Electrocautery Instruments
- Electrosurgical Instruments
- Electrocautery Devices
- robotic instruments
- Other Instruments
By Technology
- Non-robotic Surgery
- Robotic Surgery
By Type of Surgery
- Cardiothoracic Surgery
- Gastrointestinal Surgery
- Orthopedic Surgery
- Gynecological Surgery
- Cosmetic & Bariatric Surgery
- Urological Surgery
- Other Surgeries
By End User
- Hospitals and Specialty Clinics
- Ambulatory Surgery Centers
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
-
Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East Africa
- GCC Countries
Recent Developments of Minimally Invasive Surgical Instruments Industry:
- In May 2024, Intuitive received FDA clearance for the fifth-generation robotic system, da Vinci 5.
- In January 2024, Boston Scientific Corporation entered into an agreement to acquire Axonics, Inc. This will enable the company’s entry into sacral neuromodulation, a high-growth adjacency with opportunities to expand patients' access to care.
- In November 2023, Medtronic received approval from the United States Food and Drug Administration (FDA) for the Symplicity Spyral renal denervation (RDN) system, also known as the Simplicity blood pressure procedure, for the treatment of hypertension.
- In November 2023, Johnson & Johnson MedTech announced that the MONARCH Platform and MONARCH Bronchoscope have received regulatory approval in China.
Frequently Asked Questions (FAQ):
What are the recent trends affecting the minimally invasive surgical instruments market?
The recent trends impacting the minimally invasive surgical instruments market include the increasing incidence of chronic illnesses, and the rising integration of advanced robotics within Ambulatory Surgical Centers (ASCs).
Who are the key players in the minimally invasive surgical instruments market?
The key players in this market are Medtronic PLC (US), Johnson & Johnson (US), Intuitive Surgical Inc. (US), Boston Scientific Corporation (US), Stryker Corporation (US), Abbott Laboratories, Inc. (US), B. Braun SE (Germany), Conmed Corporation (US), Smith + Nephew (UK), Zimmer Biomet Holdings, Inc. (US), Becton, Dickinson and Company (US), The Cooper Companies Inc. (US), Surgical Innovations Group PLC(UK), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation(Japan) .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 53)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SEGMENTATION
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 RECESSION IMPACT
2 RESEARCH METHODOLOGY (Page No. - 59)
2.1 RESEARCH DATA
FIGURE 1 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY: RESEARCH DESIGN METHODOLOGY
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.1.2.4 Breakdown of primary interviews
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Growth forecast
2.2.1.4 CAGR projections
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2.2 TOP-DOWN APPROACH
FIGURE 6 MARKET: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE
2.5 ASSUMPTIONS & LIMITATIONS
2.5.1 GROWTH RATE ASSUMPTIONS
2.5.2 LIMITATIONS
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: MARKET
2.7 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY (Page No. - 73)
FIGURE 8 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 9 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
FIGURE 10 MARKET, BY TYPE OF SURGERY, 2024 VS. 2029 (USD MILLION)
FIGURE 11 MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 12 MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 77)
4.1 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET OVERVIEW
FIGURE 13 GROWING PREVALENCE OF TARGET DISEASES AND INCREASING NUMBER OF SURGERIES WORLDWIDE TO DRIVE MARKET GROWTH
4.2 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY SHARE, BY PRODUCT, 2024 VS. 2029
FIGURE 14 HANDHELD INSTRUMENTS SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2029
4.3 MARKET SHARE, BY TECHNOLOGY, 2024 VS. 2029
FIGURE 15 NON-ROBOTIC SURGERY SEGMENT TO ACCOUNT FOR LARGER MARKET SHARE IN 2029
4.4 MARKET SHARE, BY TYPE OF SURGERY, 2024 VS. 2029
FIGURE 16 CARDIOTHORACIC SURGERY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.5 MARKET SHARE, BY END USER, 2024 VS. 2029
FIGURE 17 HOSPITALS & SPECIALTY CLINICS TO DOMINATE MARKET DURING FORECAST PERIOD
4.6 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE MARKET DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 83)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing number of surgical procedures worldwide
5.2.1.2 Advantages of MIS over open surgeries
5.2.1.3 Increasing investments, funds, and grants by governments and other organizations worldwide
TABLE 2 MAJOR DEVELOPMENTS IN FUNDING ORGANIZATIONS
5.2.2 RESTRAINTS
5.2.2.1 Changing regulatory landscape in medical devices
5.2.2.2 High overhead cost of surgical procedures with limited reimbursement
5.2.3 OPPORTUNITIES
5.2.3.1 Improving healthcare infrastructure in emerging markets
5.2.3.2 Increasing number of ASCs
FIGURE 20 US: NUMBER OF AMBULATORY SURGERY CENTERS, 2012–2022
TABLE 3 MEDICARE FEE-FOR-SERVICE DIFFERENCES IN FACILITY FEE PAYMENTS, ASCS VS. HOPDS, 2021
5.2.4 CHALLENGES
5.2.4.1 High degree of market consolidation
5.2.4.2 Product recalls witnessed by major market players
TABLE 4 LIST OF PRODUCT RECALLS
5.3 PRICING ANALYSIS
5.3.1 AVERAGE SELLING PRICE OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT
TABLE 5 AVERAGE SELLING PRICE OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2021–2023
5.3.2 AVERAGE SELLING PRICE OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY REGION
TABLE 6 AVERAGE SELLING PRICE OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY REGION (2023)
5.4 PATENT ANALYSIS
FIGURE 21 PATENT ANALYSIS FOR MINIMALLY INVASIVE SURGICAL INSTRUMENTS (JANUARY 2014–DECEMBER 2023)
5.4.1 LIST OF MAJOR PATENTS
5.5 VALUE CHAIN ANALYSIS
FIGURE 22 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY: VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 23 MARKET: SUPPLY CHAIN ANALYSIS
5.7 TRADE ANALYSIS
5.7.1 TRADE ANALYSIS FOR NEEDLES, CATHETERS, AND CANNULAS
TABLE 7 IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAS, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 8 EXPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAS, BY COUNTRY, 2019–2023 (USD MILLION)
5.8 ECOSYSTEM ANALYSIS
FIGURE 24 MARKET: ECOSYSTEM ANALYSIS
TABLE 9 MARKET: ROLE IN ECOSYSTEM
5.9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 25 MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 10 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 REGULATORY LANDSCAPE
5.10.1 REGULATORY SCENARIO
5.10.1.1 North America
5.10.1.1.1 US
TABLE 11 US FDA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.10.1.1.2 Canada
5.10.1.2 Europe
5.10.1.3 Asia Pacific
5.10.1.3.1 China
TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.10.1.3.2 Japan
5.10.1.3.3 India
5.10.1.4 Latin America
5.10.1.4.1 Brazil
5.10.1.4.2 Mexico
5.10.1.5 Middle East
5.10.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11 TECHNOLOGY ANALYSIS
5.11.1 KEY TECHNOLOGIES
5.11.1.1 Endoscopes
5.11.1.2 Laparoscopes
5.11.2 COMPLEMENTARY TECHNOLOGIES
5.11.2.1 Electrosurgical instruments
5.11.2.2 Robotic-assisted surgery
5.11.3 ADJACENT TECHNOLOGIES
5.11.3.1 Digital solutions
5.11.3.2 Medical/Surgical imaging
5.12 KEY CONFERENCES & EVENTS IN 2024–2025
TABLE 15 MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.13.1 REVENUE SHIFT & REVENUE POCKETS FOR MARKET
FIGURE 26 REVENUE SHIFT IN MARKET
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS FOR END USERS
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS FOR END USERS (%)
5.14.2 BUYING CRITERIA
FIGURE 28 KEY BUYING CRITERIA OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS FOR END USERS
TABLE 17 KEY BUYING CRITERIA OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS FOR END USERS
5.15 INVESTMENT & FUNDING SCENARIO
FIGURE 29 MARKET: INVESTMENT & FUNDING SCENARIO
6 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT (Page No. - 115)
6.1 INTRODUCTION
TABLE 18 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 19 MARKET, BY TYPE, 2022–2029 (MILLION UNITS)
6.2 HANDHELD INSTRUMENTS
TABLE 20 KEY PRODUCTS IN HANDHELD INSTRUMENTS MARKET
TABLE 21 MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 22 MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 23 NORTH AMERICA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 24 EUROPE: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 25 ASIA PACIFIC: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 26 LATIN AMERICA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.2.1 GRASPERS
6.2.1.1 Increased patient safety and better reach provided by rotator graspers to drive market growth
TABLE 27 KEY PRODUCTS IN GRASPERS MARKET
TABLE 28 MINIMALLY INVASIVE GRASPERS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.2 RETRACTORS/ELEVATORS
6.2.2.1 Growing markets for spinal, orthopedic, and endoscopic surgical procedures to support adoption of retractors/elevators
TABLE 29 KEY PRODUCTS IN RETRACTORS/ELEVATORS MARKET
TABLE 30 MINIMALLY INVASIVE RETRACTORS/ELEVATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.3 SUTURING INSTRUMENTS
6.2.3.1 Need for skilled professionals for proper placement of sutures to challenge growth
TABLE 31 KEY PRODUCTS IN SUTURING INSTRUMENTS MARKET
TABLE 32 MINIMALLY INVASIVE SUTURING INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.4 DILATORS
6.2.4.1 Safe and efficient surgical-site access to support adoption of dilators
TABLE 33 MINIMALLY INVASIVE DILATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.5 OTHER HANDHELD INSTRUMENTS
TABLE 34 KEY PRODUCTS IN OTHER HANDHELD INSTRUMENTS MARKET
TABLE 35 OTHER MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3 INFLATION DEVICES
TABLE 36 MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 37 MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 38 NORTH AMERICA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 EUROPE: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 40 ASIA PACIFIC: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 41 LATIN AMERICA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.1 BALLOONS
6.3.1.1 Large number of angioplasty procedures carried out across globe to drive market growth
TABLE 42 KEY PRODUCTS IN BALLOONS MARKET
TABLE 43 MINIMALLY INVASIVE BALLOONS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.2 BALLOON INFLATION DEVICES
6.3.2.1 Growing adoption of balloon inflation devices to drive growth
TABLE 44 MINIMALLY INVASIVE BALLOON INFLATION DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.4 SURGICAL SCOPES
TABLE 45 KEY PRODUCTS IN SURGICAL SCOPES MARKET
TABLE 46 MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 47 MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (UNITS)
TABLE 48 MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 49 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50 EUROPE: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 51 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 52 LATIN AMERICA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.4.1 LAPAROSCOPES
6.4.1.1 Increasing number of laparoscopic surgeries and reduction in overall surgery cost to boost market growth
TABLE 53 KEY PRODUCTS IN LAPAROSCOPES MARKET
TABLE 54 MINIMALLY INVASIVE LAPAROSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.4.2 UROLOGY ENDOSCOPES
6.4.2.1 Growing prevalence of urinary tract infections to drive market
TABLE 55 MINIMALLY INVASIVE UROLOGY ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.4.3 ARTHROSCOPES
6.4.3.1 Increasing prevalence of rheumatoid arthritis to propel market growth
TABLE 56 KEY PRODUCTS IN ARTHROSCOPES MARKET
TABLE 57 MINIMALLY INVASIVE ARTHROSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.4.4 NEUROENDSCOPES
6.4.4.1 Increasing prevalence of brain cancer to boost market
TABLE 58 MINIMALLY INVASIVE NEUROENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.4.5 OTHER SURGICAL SCOPES
TABLE 59 OTHER MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.5 CUTTING INSTRUMENTS
TABLE 60 KEY PRODUCTS IN CUTTING INSTRUMENTS MARKET
TABLE 61 MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 62 MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 63 NORTH AMERICA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 64 EUROPE: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65 ASIA PACIFIC: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 LATIN AMERICA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.5.1 TROCARS
6.5.1.1 Improved trocar designs to boost adoption
TABLE 67 KEY PRODUCTS IN TROCARS MARKET
TABLE 68 MINIMALLY INVASIVE TROCARS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.5.2 OTHER CUTTING INSTRUMENTS
TABLE 69 KEY PRODUCTS IN OTHER CUTTING INSTRUMENTS MARKET
TABLE 70 OTHER MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.6 GUIDING DEVICES
TABLE 71 KEY PRODUCTS IN GUIDING DEVICES MARKET
TABLE 72 MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 73 MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 74 NORTH AMERICA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 EUROPE: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 76 ASIA PACIFIC: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 77 LATIN AMERICA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.6.1 GUIDING CATHETERS
6.6.1.1 Availability of customized catheters for specific inventions to drive demand
TABLE 78 KEY PRODUCTS IN GUIDING CATHETERS MARKET
TABLE 79 MINIMALLY INVASIVE GUIDING CATHETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.6.2 GUIDEWIRES
6.6.2.1 Growing adoption of guidewires to fuel market growth
TABLE 80 KEY PRODUCTS IN GUIDEWIRES MARKET
TABLE 81 MINIMALLY INVASIVE GUIDEWIRES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.7 ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS
TABLE 82 KEY PRODUCTS IN ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET
TABLE 83 MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 84 MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 85 NORTH AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 EUROPE: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 87 ASIA PACIFIC: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 88 LATIN AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.7.1 ELECTROSURGICAL INSTRUMENTS
6.7.1.1 Electrosurgical instruments to grow at highest CAGR during forecast period
TABLE 89 KEY PRODUCTS IN ELECTROSURGICAL INSTRUMENTS MARKET
TABLE 90 MINIMALLY INVASIVE ELECTROSURGICAL INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.7.2 ELECTROCAUTERY DEVICES
6.7.2.1 Increasing number of plastic surgeries to drive market for electrocautery devices
TABLE 91 MINIMALLY INVASIVE ELECTROCAUTERY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.8 ROBOTIC INSTRUMENTS
6.8.1 GROWING POPULARITY OF ROBOTIC SURGERY TO PROPEL MARKET GROWTH
TABLE 92 KEY PRODUCTS IN ROBOTIC INSTRUMENTS MARKET
TABLE 93 MINIMALLY INVASIVE ROBOTIC INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 94 NORTH AMERICA: MINIMALLY INVASIVE ROBOTIC INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 EUROPE: MINIMALLY INVASIVE ROBOTIC INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 ASIA PACIFIC: MINIMALLY INVASIVE ROBOTIC INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 97 LATIN AMERICA: MINIMALLY INVASIVE ROBOTIC INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.9 OTHER PRODUCTS
TABLE 98 KEY PRODUCTS IN OTHER PRODUCTS MARKET
TABLE 99 OTHER MINIMALLY INVASIVE PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 100 NORTH AMERICA: OTHER MINIMALLY INVASIVE PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 101 EUROPE: OTHER MINIMALLY INVASIVE PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 102 ASIA PACIFIC: OTHER MINIMALLY INVASIVE PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 103 LATIN AMERICA: OTHER MINIMALLY INVASIVE PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
7 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY (Page No. - 174)
7.1 INTRODUCTION
TABLE 104 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY, BY TECHNOLOGY, 2022–2029 (USD MILLION)
7.2 NON-ROBOTIC SURGERY
7.2.1 INCREASING ADOPTION OF MIS SURGERIES TO PROPEL MARKET GROWTH
TABLE 105 MARKET FOR NON-ROBOTIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
TABLE 106 NORTH AMERICA: MARKET FOR NON-ROBOTIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 107 EUROPE: MARKET FOR NON-ROBOTIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 108 ASIA PACIFIC: MARKET FOR NON-ROBOTIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 109 LATIN AMERICA: MARKET FOR NON-ROBOTIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
7.3 ROBOTIC SURGERY
7.3.1 ADVANTAGES ASSOCIATED WITH ROBOTIC-ASSISTED SURGERY TO SUPPORT MARKET GROWTH
TABLE 110 AUSTRALIA AND NEW ZEALAND: ROBOTIC-ASSISTED PROCEDURES, BY SPECIALTY, 2018–2022 (NUMBER OF PROCEDURES)
TABLE 111 MARKET FOR ROBOTIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
TABLE 112 NORTH AMERICA: MARKET FOR ROBOTIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 113 EUROPE: MARKET FOR ROBOTIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 114 ASIA PACIFIC: MARKET FOR ROBOTIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 LATIN AMERICA: MARKET FOR ROBOTIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
8 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY (Page No. - 182)
8.1 INTRODUCTION
TABLE 116 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
8.2 CARDIOTHORACIC SURGERY
8.2.1 GROWING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET GROWTH
TABLE 117 MARKET FOR CARDIOTHORACIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
TABLE 118 NORTH AMERICA: MARKET FOR CARDIOTHORACIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 119 EUROPE: MARKET FOR CARDIOTHORACIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 120 ASIA PACIFIC: MARKET FOR CARDIOTHORACIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121 LATIN AMERICA: MARKET FOR CARDIOTHORACIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
8.3 GASTROINTESTINAL SURGERY
8.3.1 GROWING BURDEN OF COLORECTAL CANCER TO SUPPORT MARKET GROWTH
TABLE 122 MARKET FOR GASTROINTESTINAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
TABLE 123 NORTH AMERICA: MARKET FOR GASTROINTESTINAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124 EUROPE: MARKET FOR GASTROINTESTINAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 125 ASIA PACIFIC: MARKET FOR GASTROINTESTINAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 126 LATIN AMERICA: MARKET FOR GASTROINTESTINAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
8.4 ORTHOPEDIC SURGERY
8.4.1 INCREASING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN ORTHOPEDIC AILMENTS TO BOOST MARKET
TABLE 127 MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
TABLE 128 NORTH AMERICA: MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129 EUROPE: MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 130 ASIA PACIFIC: MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 131 LATIN AMERICA: MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
8.5 GYNECOLOGICAL SURGERY
8.5.1 GROWING NUMBER OF LAPAROSCOPIC HYSTERECTOMIES TO SUPPORT MARKET GROWTH
TABLE 132 MARKET FOR GYNECOLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
TABLE 133 NORTH AMERICA: MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 134 EUROPE: MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135 ASIA PACIFIC: MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 136 LATIN AMERICA: MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
8.6 BARIATRIC SURGERY
8.6.1 INCREASING PREVALENCE OF OBESITY TO FUEL GROWTH
TABLE 137 MARKET FOR BARIATRIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
TABLE 138 NORTH AMERICA: MARKET FOR BARIATRIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 139 EUROPE: MARKET FOR BARIATRIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 140 ASIA PACIFIC: MARKET FOR BARIATRIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 141 LATIN AMERICA: MARKET FOR BARIATRIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
8.7 COSMETIC SURGERY
8.7.1 GROWING PREFERENCE FOR COSMETIC PROCEDURES TO PROPEL MARKET
TABLE 142 MARKET FOR COSMETIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
TABLE 143 NORTH AMERICA: MARKET FOR COSMETIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 144 EUROPE: MARKET FOR COSMETIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 ASIA PACIFIC: MARKET FOR COSMETIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 146 LATIN AMERICA: MARKET FOR COSMETIC SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
8.8 UROLOGICAL SURGERY
8.8.1 COST BENEFITS OF LAPAROSCOPIC CYSTOSCOPY TO BOOST ADOPTION
TABLE 147 MARKET FOR UROLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION)
TABLE 148 NORTH AMERICA: MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 149 EUROPE: MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 150 ASIA PACIFIC: MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 151 LATIN AMERICA: MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
8.9 OTHER SURGERIES
TABLE 152 MARKET FOR OTHER SURGERIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 153 NORTH AMERICA: MARKET FOR OTHER SURGERIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 154 EUROPE: MARKET FOR OTHER SURGERIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 155 ASIA PACIFIC: MARKET FOR OTHER SURGERIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 156 LATIN AMERICA: MARKET FOR OTHER SURGERIES, BY COUNTRY, 2022–2029 (USD MILLION)
9 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER (Page No. - 208)
9.1 INTRODUCTION
TABLE 157 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
9.2 HOSPITALS & SPECIALTY CLINICS
9.2.1 GROWING NUMBER OF HOSPITALS AND INCREASING GOVERNMENT INVESTMENTS TO DRIVE MARKET GROWTH
TABLE 158 MARKET FOR HOSPITALS & SPECIALTY CLINICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 159 NORTH AMERICA: MARKET FOR HOSPITALS & SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 160 EUROPE: MARKET FOR HOSPITALS & SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 161 ASIA PACIFIC: MARKET FOR HOSPITALS & SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 162 LATIN AMERICA: MARKET FOR HOSPITALS & SPECIALTY CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
9.3 AMBULATORY SURGERY CENTERS
9.3.1 LOWER COST AND SHORTER PATIENT STAYS TO PROPEL MARKET GROWTH
TABLE 163 MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 164 NORTH AMERICA: MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 165 EUROPE: MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 166 ASIA PACIFIC: MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 167 LATIN AMERICA: MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
10 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY REGION (Page No. - 216)
10.1 INTRODUCTION
TABLE 168 GLOBAL NUMBER OF SURGICAL PROCEDURES, 2021
TABLE 169 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SNAPSHOT
TABLE 170 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 171 NORTH AMERICA: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 172 NORTH AMERICA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 173 NORTH AMERICA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 174 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 175 NORTH AMERICA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 176 NORTH AMERICA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 177 NORTH AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 178 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 179 NORTH AMERICA: MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 180 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.2.1 NORTH AMERICA: RECESSION IMPACT
10.2.2 US
10.2.2.1 US to dominate North American market during forecast period
TABLE 181 US: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 182 US: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 183 US: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 184 US: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 185 US: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 186 US: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 187 US: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 188 US: INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 189 US: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 190 US: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Increasing prevalence of cancer to favor market growth
TABLE 191 CANADA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 192 CANADA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 193 CANADA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 194 CANADA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 195 CANADA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 196 CANADA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 197 CANADA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 198 CANADA: INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 199 CANADA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 200 CANADA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3 EUROPE
TABLE 201 EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 202 EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 203 EUROPE: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 204 EUROPE: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 205 EUROPE: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 206 EUROPE: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 207 EUROPE: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 208 EUROPE: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 209 EUROPE: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 210 EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 211 EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3.1 EUROPE: RECESSION IMPACT
10.3.2 GERMANY
10.3.2.1 Rising healthcare expenses in Germany to boost use of MIS instruments
TABLE 212 GERMANY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 213 GERMANY: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 214 GERMANY: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 215 GERMANY: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 216 GERMANY: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 217 GERMANY: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 218 GERMANY: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 219 GERMANY: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 220 GERMANY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 221 GERMANY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3.3 UK
10.3.3.1 High incidence of cancer in UK to boost adoption of MIS instruments
TABLE 222 UK: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 223 UK: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 224 UK: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 225 UK: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 226 UK: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 227 UK: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 228 UK: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 229 UK: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 230 UK: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 231 UK: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3.4 FRANCE
10.3.4.1 Increasing number of surgeries in France to drive market growth
TABLE 232 FRANCE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 233 FRANCE: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 234 FRANCE: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 235 FRANCE: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 236 FRANCE: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 237 FRANCE: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 238 FRANCE: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 239 FRANCE: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 240 FRANCE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 241 FRANCE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Increasing incidence of cancer to support market growth in Italy
TABLE 242 ITALY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 243 ITALY: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 244 ITALY: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 245 ITALY: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 246 ITALY: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 247 ITALY: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 248 ITALY: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 249 ITALY: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 250 ITALY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 251 ITALY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Increasing incidence of CVD to boost adoption of MIS
TABLE 252 SPAIN: MACROECONOMIC INDICATORS
TABLE 253 SPAIN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 254 SPAIN: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 255 SPAIN: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 256 SPAIN: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 257 SPAIN: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 258 SPAIN: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 259 SPAIN: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 260 SPAIN: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 261 SPAIN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 262 SPAIN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 263 REST OF EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 264 REST OF EUROPE: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 265 REST OF EUROPE: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 266 REST OF EUROPE: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 267 REST OF EUROPE: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 268 REST OF EUROPE: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 269 REST OF EUROPE: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 270 REST OF EUROPE: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 271 REST OF EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 272 REST OF EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 31 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SNAPSHOT
TABLE 273 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 274 ASIA PACIFIC: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 275 ASIA PACIFIC: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 276 ASIA PACIFIC: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 277 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 278 ASIA PACIFIC: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 279 ASIA PACIFIC: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 280 ASIA PACIFIC: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 281 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 282 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 283 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.4.1 ASIA PACIFIC: RECESSION IMPACT
10.4.2 CHINA
10.4.2.1 Large population in China to drive market
TABLE 284 CHINA: MACROECONOMIC INDICATORS
TABLE 285 CHINA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 286 CHINA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 287 CHINA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 288 CHINA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 289 CHINA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 290 CHINA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 291 CHINA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 292 CHINA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 293 CHINA: MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 294 CHINA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.4.3 JAPAN
10.4.3.1 Rising geriatric population in Japan to increase prevalence of chronic conditions
TABLE 295 JAPAN: MACROECONOMIC INDICATORS
TABLE 296 JAPAN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 297 JAPAN: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 298 JAPAN: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 299 JAPAN: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 300 JAPAN: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 301 JAPAN: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 302 JAPAN: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 303 JAPAN: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 304 JAPAN: MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 305 JAPAN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Healthcare infrastructure improvements and increasing geriatric population to drive market growth in India
TABLE 306 INDIA: MACROECONOMIC INDICATORS
TABLE 307 INDIA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 308 INDIA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 309 INDIA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 310 INDIA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 311 INDIA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 312 INDIA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 313 INDIA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 314 INDIA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 315 INDIA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 316 INDIA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 317 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 318 REST OF ASIA PACIFIC: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 319 REST OF ASIA PACIFIC: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 320 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 321 REST OF ASIA PACIFIC: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 322 REST OF ASIA PACIFIC: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 323 REST OF ASIA PACIFIC: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 324 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 325 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 326 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.5 LATIN AMERICA
TABLE 327 LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 328 LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 329 LATIN AMERICA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 330 LATIN AMERICA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 331 LATIN AMERICA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 332 LATIN AMERICA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 333 LATIN AMERICA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 334 LATIN AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 335 LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 336 LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 337 LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.5.1 LATIN AMERICA: RECESSION IMPACT
10.5.2 BRAZIL
10.5.2.1 Healthcare infrastructure improvements and increasing cancer incidence to drive market growth
TABLE 338 BRAZIL: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 339 BRAZIL: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 340 BRAZIL: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 341 BRAZIL: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 342 BRAZIL: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 343 BRAZIL: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 344 BRAZIL: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 345 BRAZIL: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 346 BRAZIL: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 347 BRAZIL: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.5.3 MEXICO
10.5.3.1 Growing medical tourism to drive market growth
TABLE 348 MEXICO: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 349 MEXICO: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 350 MEXICO: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 351 MEXICO: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 352 MEXICO: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 353 MEXICO: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 354 MEXICO: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 355 MEXICO: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 356 MEXICO: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 357 MEXICO: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.5.4 REST OF LATIN AMERICA
TABLE 358 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 359 REST OF LATIN AMERICA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 360 REST OF LATIN AMERICA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 361 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 362 REST OF LATIN AMERICA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 363 REST OF LATIN AMERICA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 364 REST OF LATIN AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 365 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 366 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 367 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 INCREASING HEALTHCARE EXPENDITURE TO BOOST MARKET
TABLE 368 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 369 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 370 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 371 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 372 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 373 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 374 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 375 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 376 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 377 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
10.7 GCC COUNTRIES
10.7.1 SUPPORTIVE GOVERNMENT INITIATIVES TO FUEL GROWTH
TABLE 378 GCC COUNTRIES: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 379 GCC COUNTRIES: MINIMALLY INVASIVE HANDHELD INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 380 GCC COUNTRIES: MINIMALLY INVASIVE INFLATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 381 GCC COUNTRIES: MINIMALLY INVASIVE SURGICAL SCOPES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 382 GCC COUNTRIES: MINIMALLY INVASIVE CUTTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 383 GCC COUNTRIES: MINIMALLY INVASIVE GUIDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 384 GCC COUNTRIES: MINIMALLY INVASIVE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 385 GCC COUNTRIES: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 386 GCC COUNTRIES: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2022–2029 (USD MILLION)
TABLE 387 GCC COUNTRIES: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.7.2 GCC COUNTRIES: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE (Page No. - 328)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET
TABLE 388 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY: STRATEGIES ADOPTED
11.3 REVENUE ANALYSIS
FIGURE 32 REVENUE ANALYSIS OF KEY PLAYERS IN MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY, 2018–2023
11.4 MARKET SHARE ANALYSIS
FIGURE 33 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY, 2023
TABLE 389 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 LIST OF EVALUATED VENDORS
11.5.2 STARS
11.5.3 EMERGING LEADERS
11.5.4 PERVASIVE PLAYERS
11.5.5 PARTICIPANTS
FIGURE 34 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
11.5.6 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.6.1 Company footprint
FIGURE 35 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY: COMPANY FOOTPRINT
11.5.6.2 Region footprint
TABLE 390 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY: REGION FOOTPRINT
11.5.6.3 Technology footprint
TABLE 391 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY: TECHNOLOGY FOOTPRINT
11.5.6.4 Type of surgery footprint
TABLE 392 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY: TYPE OF SURGERY FOOTPRINT
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
FIGURE 36 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
TABLE 393 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 394 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
11.7 COMPANY VALUATION & FINANCIAL METRICS
FIGURE 37 EV/EBITDA OF KEY VENDORS
FIGURE 38 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
11.8 BRAND/PRODUCT COMPARISON
FIGURE 39 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY: PRODUCT/BRAND COMPARISON
11.8.1 MEDTRONIC PLC
11.8.2 JOHNSON & JOHNSON
11.8.3 STRYKER CORPORATION
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES & APPROVALS
TABLE 395 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2024
11.9.2 DEALS
TABLE 396 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY: DEALS, JANUARY 2021–APRIL 2024
11.9.3 EXPANSIONS
TABLE 397 MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY: EXPANSIONS, JANUARY 2021–APRIL 2024
12 COMPANY PROFILES (Page No. - 345)
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 MEDTRONIC PLC
TABLE 398 MEDTRONIC PLC: COMPANY OVERVIEW
FIGURE 40 MEDTRONIC PLC: COMPANY SNAPSHOT (2023)
TABLE 399 MEDTRONIC PLC: PRODUCTS OFFERED
TABLE 400 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2024
12.1.2 JOHNSON & JOHNSON
TABLE 401 JOHNSON & JOHNSON: COMPANY OVERVIEW
FIGURE 41 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2023)
TABLE 402 JOHNSON & JOHNSON: PRODUCTS OFFERED
TABLE 403 JOHNSON & JOHNSON: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2024
12.1.3 INTUITIVE SURGICAL, INC.
TABLE 404 INTUITIVE SURGICAL, INC.: BUSINESS OVERVIEW
FIGURE 42 INTUITIVE SURGICAL, INC.: COMPANY SNAPSHOT (2023)
TABLE 405 INTUITIVE SURGICAL, INC.: PRODUCTS OFFERED
TABLE 406 INTUITIVE SURGICALS, INC.: PRODUCT APPROVALS, JANUARY 2021–APRIL 2024
12.1.4 BOSTON SCIENTIFIC CORPORATION
TABLE 407 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 43 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
TABLE 408 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 409 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2021–APRIL 2024
TABLE 410 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021–APRIL 2024
12.1.5 STRYKER CORPORATION
TABLE 411 STRYKER CORPORATION: BUSINESS OVERVIEW
FIGURE 44 STRYKER CORPORATION: COMPANY SNAPSHOT (2023)
TABLE 412 STRYKER CORPORATION: PRODUCTS OFFERED
12.1.6 ABBOTT LABORATORIES, INC.
TABLE 413 ABBOTT LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 45 ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
TABLE 414 ABBOTT LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 415 ABBOTT LABORATORIES, INC.: DEALS, JANUARY 2021–APRIL 2024
12.1.7 SMITH+NEPHEW
TABLE 416 SMITH+NEPHEW: BUSINESS OVERVIEW
FIGURE 46 SMITH+NEPHEW: COMPANY SNAPSHOT (2023)
TABLE 417 SMITH+NEPHEW: PRODUCTS OFFERED
TABLE 418 SMITH+NEPHEW: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2024
12.1.8 B. BRAUN SE
TABLE 419 B. BRAUN SE: BUSINESS OVERVIEW
FIGURE 47 B. BRAUN SE: COMPANY SNAPSHOT (2023)
TABLE 420 B. BRAUN SE: PRODUCTS OFFERED
12.1.9 BECTON, DICKINSON AND COMPANY
TABLE 421 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 48 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
TABLE 422 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 423 BECTON, DICKINSON AND COMPANY: EXPANSIONS, JANUARY 2021–APRIL 2024
12.1.10 CONMED CORPORATION
TABLE 424 CONMED CORPORATION: BUSINESS OVERVIEW
FIGURE 49 CONMED CORPORATION: COMPANY SNAPSHOT (2023)
TABLE 425 CONMED CORPORATION: PRODUCTS OFFERED
12.1.11 ZIMMER BIOMET HOLDINGS, INC.
TABLE 426 ZIMMER BIOMET HOLDINGS, INC.: BUSINESS OVERVIEW
FIGURE 50 ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT (2023)
TABLE 427 ZIMMER BIOMET HOLDINGS, INC.: PRODUCTS OFFERED
12.1.12 THE COOPER COMPANIES, INC.
TABLE 428 THE COOPER COMPANIES, INC.: BUSINESS OVERVIEW
FIGURE 51 THE COOPER COMPANIES, INC.: COMPANY SNAPSHOT (2023)
TABLE 429 THE COOPER COMPANIES, INC.: PRODUCTS OFFERED
TABLE 430 THE COOPER COMPANIES, INC.: DEALS, JANUARY 2021–APRIL 2024
12.1.13 KONINKLIJKE PHILIPS N.V.
TABLE 431 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 52 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
TABLE 432 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
TABLE 433 KONINKLIJKE PHILIPS N.V.: PRODUCT APPROVALS, JANUARY 2021–APRIL 2024
TABLE 434 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–APRIL 2024
12.1.14 SURGICAL INNOVATIONS GROUP PLC
TABLE 435 SURGICAL INNOVATIONS GROUP PLC: BUSINESS OVERVIEW
FIGURE 53 SURGICAL INNOVATIONS GROUP PLC: COMPANY SNAPSHOT (2022)
TABLE 436 SURGICAL INNOVATIONS GROUP PLC: PRODUCTS OFFERED
12.1.15 FUJIFILM HOLDINGS CORPORATION
TABLE 437 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
FIGURE 54 FUJIFILM HOLDING CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 438 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
TABLE 439 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2024
12.2 OTHER PLAYERS
12.2.1 HOYA CORPORATION
TABLE 440 HOYA CORPORATION: COMPANY OVERVIEW
12.2.2 KARL STORZ SE & CO. KG
TABLE 441 KARL STORZ SE & CO. KG: COMPANY OVERVIEW
12.2.3 APPLIED MEDICAL RESOURCES CORPORATION
TABLE 442 APPLIED MEDICAL RESOURCES CORPORATION: COMPANY OVERVIEW
12.2.4 KLS MARTIN GROUP
TABLE 443 KLS MARTIN GROUP: COMPANY OVERVIEW
12.2.5 SCANLAN INTERNATIONAL, INC.
TABLE 444 SCANLAN INTERNATIONAL, INC.: COMPANY OVERVIEW
12.2.6 WEXLER SURGICAL
TABLE 445 WEXLER SURGICAL: COMPANY OVERVIEW
12.2.7 STRAUSS SURGICAL
TABLE 446 STRAUSS SURGICAL: COMPANY OVERVIEW
12.2.8 AMNOTEC INTERNATIONAL GMBH
TABLE 447 AMNOTEC INTERNATIONAL GMBH: COMPANY OVERVIEW
12.2.9 ENDOMED SYSTEMS GMBH
TABLE 448 ENDOMED SYSTEMS GMBH: COMPANY OVERVIEW
12.2.10 TROKAMED GMBH
TABLE 449 TROKAMED GMBH: COMPANY OVERVIEW
12.2.11 SURGICAL HOLDINGS
TABLE 450 SURGICAL HOLDINGS: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 420)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
The objective of the study is analyzing the key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies. To track companies’ developments such as product launch, approval, acquisition, agreement and expansion of the leading players, the competitive landscape of the minimally invasive surgical instruments market to analyzes market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.
The following is a breakdown of the primary respondents:
Breakdown of Primary Participants:
Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2022, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
|
COMPANY NAME |
DESIGNATION |
|
Medtronic PLC (US) |
Marketing Manager |
|
Johnson & Johnson (US) |
Senior Product Manager |
|
Intuitive Surgical Inc. (US) |
Marketing Manager |
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the home healthcare market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the minimally invasive surgical instruments market have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Global Minimally Invasive Surgical Instruments Market Size: Bottom-Up Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Global Minimally Invasive Surgical Instruments Market Size: Top-Down Approach
Data Triangulation
After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Minimally invasive surgery (MIS) is a surgical procedure done in a manner that causes little to no trauma or injury to a patient. MIS is executed through a cannula using lasers, endoscopes or laparoscopes. MIS involves less bleeding, smaller amounts of anesthesia, less pain, and minimal scarring than other procedures. The surgical instruments used to make minute incisions in the body and perform MIS procedures are minimally invasive.
Key Stakeholders
- Senior Management
- End User
- Finance/Procurement Department
- R&D Department
Report Objectives
- To define, describe, segment, and forecast the minimally invasive surgical instruments market by product, technology, type of surgery, end user and region
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to six regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, Latin America, and GCC countries
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launch, acquisition, agreement, partnership and expansion in the minimally invasive surgical instruments market
- To benchmark players within the minimally invasive surgical instruments market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
Available Customizations
MarketsandMarkets offers the following customizations for this market report
Country Information
- Additional country-level analysis of the minimally invasive surgical instruments market
Company profiles
- Additional five company profiles of players operating in the minimally invasive surgical instruments market.
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the minimally invasive surgical instruments market
Generating Response ...
Growth opportunities and latent adjacency in Minimally Invasive Surgical Instruments Market
Which of the geographical segment is expected major share in the global Minimally Invasive Surgical Instruments Market?
In what way the COVID19 is impacting the global growth of Minimally Invasive Surgical Instruments Market?
What are the emerging technological innovations in the Minimally Invasive Surgical Instruments Market?